Nestle SA is looking to a possible sale of its skincare unit and is working with advisers to review its options, according to a report by Bloomberg.

In a bid to streamline its existing business interests, it’s said to be working with advisers such as Credit Suisse Group AG and is looking at a valuation of between $8 to $10 billion.

The company is thought to be looking at selling the dermatological arm as a whole division or in parts as a way to better focus on its core products including coffee, water and pet food.

The review is expected to carry on until the middle of next year with potential acquisition interest from the likes of Johnson & Johnson and private equity firms such as Apax Partners.